AF
ADPT icon

Allworth Financial’s Adaptive Biotechnologies ADPT Stock Holding History

Allworth Financial’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.2K Sell
1,642
-46
-3% -$705 ﹤0.01% 2770
2026
Q1 		$23.4K Buy
1,688
+142
+9% +$2.26K ﹤0.01% 2876
2025
Q4 		$25.1K Buy
1,546
+1
+0.1% +$16 ﹤0.01% 2659
2025
Q3 		$23.1K Buy
1,545
+340
+28% +$4.14K ﹤0.01% 2609
2025
Q2 		$14K Buy
1,205
+104
+9% +$945 ﹤0.01% 2731
2025
Q1 		$8.69K Buy
1,101
+26
+2% +$200 ﹤0.01% 2483
2024
Q4 		$8.61K Sell
1,075
-387
-26% -$2.13K ﹤0.01% 2497
2024
Q3 		$7.49K Sell
1,462
-177
-11% -$771 ﹤0.01% 2391
2024
Q2 		$6.62K Buy
1,639
+1,086
+196% +$3.45K ﹤0.01% 2388
2024
Q1 		$1.78K Buy
+553
New +$2.14K ﹤0.01% 2850
2023
Q4 		– Sell
-24
Closed -$131 – 3453
2023
Q3 		$131 Sell
24
-23
-49% -$152 ﹤0.01% 3293
2023
Q2 		$316 Buy
47
+24
+104% +$178 ﹤0.01% 3002
2023
Q1 		$204 Buy
+23
New +$203 ﹤0.01% 3008
2022
Q4 		– Sell
-23
Closed – – 2992
2022
Q3 		$0 Buy
+23
New +$217 ﹤0.01% 2615

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allworth Financial's ADPT Position: Q2 2026 in Review

Allworth Financial reduced its Adaptive Biotechnologies (ADPT) stake by 2.7% in Q2 2026, selling an estimated $705 and leaving 1,642 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

Allworth Financial first reported a position in ADPT in Q3 2022 and has held it in 14 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Allworth Financial held 1,642 shares of Adaptive Biotechnologies worth $35.2K as of Q2 2026.
  • Allworth Financial sold 46 Adaptive Biotechnologies shares in Q2 2026, an estimated $705.
  • Adaptive Biotechnologies made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2770 holding.
  • Allworth Financial first reported a position in Adaptive Biotechnologies in Q3 2022 and has held it in 14 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.